[PERSON]
Yoram Drucker
Featured in 2 tracked stories · first seen
Situations
NurExone Biologic strategic and financial expansion
2 clusters · 9 sources · last updated
Latest: NurExone Biologic announces Q2 2026 results and strategic expansions
NurExone Biologic Inc. is pursuing financial and operational expansion through capital raising, market positioning, and strategic partnerships. To support the transition of its ExoPTEN treatment from preclinical results
Also covered in
-
NurExone Biologic appoints David Stolick to its board of directors
[BUSINESS] · 2 sources ·